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Abstract
Purpose of review—We sought to provide a review of the recent literature regarding the 
prevalence and epidemiological trends in pelvic floor disorders (PFDs) including pelvic organ 
prolapse (POP), urinary incontinence (UI) and fecal incontinence (FI). We also examined the 
current trends in surgical treatment for these disorders and discuss future care needs.
Recent findings—Approximately one quarter of all women suffer from at least one or more 
PFDs. UI represents the most common PFD with an estimated prevalence of 15–17% while FI 
affects approximately 9% of adult women. POP is more difficult to assess with prevalence 
estimates ranging from 3–8%. Surgery for PFDs is common as 20% of women undergo stress UI 
or POP surgery over their lifetime. As the aging population grows, the number of women with 
PFDs will increase substantially and the demand for care for these disorders will continue to grow 
through the year 2050.
Summary—PFDs are a significant public health issue and they negatively impact the lives of 
millions of adult women. The projected increase in the number of women affected by PFDs over 
the next 40 years will create increased demand for providers properly trained in Female Pelvic 
Medicine and Reconstructive Surgery.
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Introduction
Pelvic floor disorders (PFDs) include pelvic organ prolapse (POP), urinary incontinence 
(UI) and fecal incontinence (FI). PFDs are prevalent medical conditions affecting the lives of 
many women throughout the world. In understanding the prevalence and various risk factors 
associated with PFDs, providers can better identify at-risk patients and provide improved 
care for those women who are already affected. In this article, we aim to provide a 
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comprehensive review of the estimated prevalence and epidemiological trends in PFDs, 
examine the current trends in surgical treatment for these disorders, and discuss future 
projections of PFDs.
Epidemiological Trends in PFD
Overall Pelvic Floor Disorders
Nygaard and colleagues demonstrated the significant public health burden of PFDs in their 
landmark study in 2008. Using National Health and Nutrition Examination Survey 
(NHANES) data from 2005 to 2006 the authors found that 23.7% of U.S. women had at 
least one PFD.(1*) In a subsequent study, our group utilized NHANES data from 2005 and 
2010 on 7,924 non-pregnant women aged 20 years and older to assess the prevalence of 
PFDs. PFDs were defined as moderate to severe UI, at least monthly FI, or symptomatic 
POP (seeing or feeling a bulge). The proportion of women suffering from at least one or 
more burdensome PFDs was 25.0% (95% CI 23.6–26.3), confirming Nygaard’s previous 
findings.(2) In addition, there was no significant trend in PFD prevalence over the 5-year 
period. Recently, these rates were further confirmed in a survey of 5,236 primiparous women 
20 years after a vaginal or cesarean delivery when Gyhagen and colleagues found that 31.7% 
had at least one symptomatic PFD and that 14.8% had two or more.(3) In examining risk 
factors for PFDs, older age was the most significant risk factor with over 50% of women 
over the age of 80 having one or more PFD.(2**) In addition to age, risk factors also 
included increased parity, elevated body mass index (BMI), prior hysterectomy, and 
presence of co-morbid diseases.(2) Gyhagen’s study found prior vaginal delivery had the 
strongest association with having all three symptomatic PFDs.(3)
Urinary Incontinence
UI represents the most common PFD and is comprised of stress urinary incontinence (SUI) 
and overactive bladder (OAB), which includes urinary urgency with or without urgency 
urinary incontinence (UUI), urinary frequency, and nocturia. In our NHANES study, we 
defined UI to include moderate to severe symptoms using the incontinence severity index, 
translating to at least weekly leakage or monthly leakage of volumes more than drops. We 
estimated that the combined prevalence of UI was 17.1% (95% CI 15.8–18.4),(2) which is 
similar to Nygaard et al. who estimated the prevalence of UI to be 15.7%.(1) As with other 
PFDs, SUI and OAB prevalence increases with age and affects up to 43.1% of women over 
40 years old.(2, 4, 5) In addition to age, previous studies have found SUI and OAB are 
associated with higher BMI, increasing waist circumference, higher parity, prior vaginal 
delivery, prior hysterectomy, smoking, depression, irritable bowel syndrome, sleep apnea, 
and presence of neurological disorders.(2, 4, 6)
Data are mixed regarding the prevalence of UI across racial/ethnic groups. In a large 
ethnically-diverse, cross-sectional Internet-based study of 10,000 survey participants, Coyne 
et al. estimated a 30.0% prevalence of lower urinary tract symptoms (including urinary 
leakage, OAB symptoms and voiding symptoms) in women aged 18–70 years.(4) The 
increased prevalence may be due to in part to their broader definition as well as a more 
diverse study population. Other studies looking at UI across ethnicities have found UI is 
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more common in non-Hispanic white women,(2, 7) SUI is highest among white women,(4, 
7) and OAB/UUI is more common in African-American women.(4, 6) However, recently 
Maserejian and colleagues failed to find a statistical difference in UI between ethnicities 
when adjusting for age.(8) Regardless, providers should proactively assess for bothersome 
OAB and SUI in all patients, with particular diligence in older populations.
Fecal Incontinence and Dual Fecal and Urinary Incontinence
FI, defined as leakage of mucus, liquid or solid stool occurring at least monthly, is estimated 
to affect 8.4% of adults(9*) and 9.4% of adult women.(2) As with other PFDs, the 
prevalence of FI increases with age with up to 15.3% of women aged 70 and older 
experiencing FI monthly.(10**) Other identified risk factors for FI are obesity, bowel 
disturbances such as diarrhea, having multiple chronic illnesses, smoking, and anal sphincter 
trauma including obstetrical injury.(2, 10, 11*) In the Nurses’ Health Study of more than 
64,000 women, the prevalence of dual UI and FI was 7.2%.(12*) Recently, using NHANES 
data from 2005 to 2010, we found a similar dual incontinence prevalence rate of 6.0% (95% 
CI 5.0–7.1) in women over 50.(13*) Risk factors for dual incontinence include older age, 
depression, co-morbidities, diarrhea, multiparity, and hysterectomy.(12,13) Notably, dual 
incontinence has a greater negative impact on quality of life than either condition alone and 
should therefore be assessed in anyone reporting UI or FI alone.(12)
Pelvic Organ Prolapse
Based on our NHANES data, POP, commonly defined as seeing or feeling a bulge, is 
estimated to affect 2.9% of women aged 20 and older.(1, 2) In a review article published as 
part of the Fifth International Collaboration on Incontinence, Barber et al. found that 
symptomatic POP was present in 3–6% of the population, but when based on vaginal 
examination was present in up to 50%.(14*) Based on the validated International 
Consultation on Incontinence Questionnaire for vaginal symptoms (ICIQ-VS), 8.4% of 
respondents reported a vaginal bulge/lump and 4.9% reported a bulge or lump outside the 
vagina among 1,832 women in the United Kingdom.(15) As with other PFDs, the prevalence 
of POP increases with age until a peak of 5.1% in women aged 60–69.(2) The declining 
prevalence of POP after age 69 may in part be due to surgical correction being performed at 
younger ages. Although only about 10–20% of symptomatic women seek medical help, both 
conservative and surgical interventions have been shown to improve quality of life.(16*) 
This again speaks to the importance of proactive screening. In addition to parity and vaginal 
delivery, non-obstetric risk factors for POP surgery include age, constipation, increasing 
weight, and chronic obstructive pulmonary disease.(17)
Trends in Surgery for PFDs
Given the high prevalence of PFDs and the fact that surgery is an effective treatment option 
for these conditions, surgeries for SUI and POP are quite common. Our group conducted a 
population-based analysis and reported that the lifetime risk of surgery for either SUI or 
POP is 20.0% (95% CI 19.9–20.2) by the age of 80 years(18**), which is dramatically 
higher than previously estimated.(19, 20) This updated analysis assessed over 10 million 
women followed for almost 25 million person-years in a longitudinal fashion to provide 
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relatively precise estimates. The risk of SUI surgery was 13.6% (95% CI 13.5–13.7) and the 
risk for POP surgery was 12.6% (95% CI 12.4–12.7) (Figure). This analysis also reported 
that the highest rates of surgery occurred in women aged 70–79 years. An analysis of 
Medicare beneficiaries supports the fact that POP surgery is common in women aged ≥ 65 
years.(21*) In other countries, POP surgery rates may differ; for example, the lifetime risk of 
POP surgery in Western Australia was reported at 19%,(22) and the cumulative incidence for 
POP surgery in the Norwegian population was estimated to be 14.6% by the age of 85 years.
(17)
An important factor to consider when discussing trends in surgery for PFDs is the impact of 
the 2008 and 2011 safety notifications issued by the Food and Drug Administration (FDA) 
regarding vaginal mesh.(23, 24) After these FDA notices, several studies have evaluated 
trends in the use of mesh for POP. In an analysis of hospital discharge data of 275,000 
women who underwent POP surgery from 2000 to 2010, there was an increase in the 
proportion of procedures which utilized mesh from 7.9% in 2000 to a peak of 32.2% in 
2006, which then declined slightly to 27.5% in 2010.(25) Our group reported that the rate of 
mesh POP procedures increased from 2005–2010 and vaginal mesh procedure comprised 
75% of mesh surgeries in a population-based study.(26) Local and/or regional trends may 
vary. For example, at a single academic medical center, vaginal mesh procedures decreased 
from 27% of all POP surgeries in early 2008 to 2% at the end of 2011,(27*) while mesh use 
increased in Portugal from 2000–2012.(28)
For SUI, midurethral slings have become the primary procedure performed and the gold 
standard SUI surgery.(29, 30) From 2000–2009, there was a dramatic decrease in SUI 
retropubic procedures with a corresponding increase in sling procedures in the U.S. Data 
from other countries, including England(31), Taiwan(32) and Korea,(33) show similar 
trends. Despite the fact that midurethral slings involve the use of vaginal mesh, no recent 
studies have assessed the impact of the FDA safety notification on the rates of SUI surgeries.
Limited recent data exist regarding trends in surgery for UUI or FI. Although sacral 
neuromodulation is a treatment option for UUI and FI, few longitudinal, population-based 
data regarding this procedure exist.(34) For FI, an analysis of inpatient hospital discharge 
data reported that the number of women who underwent a FI surgery, which did not include 
sacral neuromodulation, remained stable with 3,423 in 1998 and 3,509 in 2003.(35) Given 
that knowledge gaps exist regarding the trends in procedures for UUI and FI, future research 
should aim to address these important questions.
Future Care Needs
Over the next 40 years, the United States will experience significant growth in its aging 
population.(36) According to the 2012 U.S. Census Bureau projections the population aged 
65 or older will nearly double by 2050 from its current 43.1 million to 83.7 million to make 
up 20.9% of the U.S. population. Even more dramatically, those 85 and older are projected 
to more than double from 5.9 million in 2012 (1.9% of the U.S. population) to 18 million in 
2050 (almost 5% of the 2050 U.S. population). Of this older population, the majority will 
continue to be women making up 55% of those 65 and older in 2050.
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In order to estimate the future prevalence of PFDs in the U.S. population, our group used 
U.S. Census and NHANES data. We estimated that the number of women with PFDs will 
increase substantially by 2050 with an expected 43.8 million women having at least one 
PFD by 2050.(37**) We then estimated the annual procedure rates for SUI or POP surgery 
using the 2008 U.S. Census projections, inpatient data obtained from the 2007 Nationwide 
Inpatient Sample (the largest publicly available database of hospital discharges in the U.S.) 
and outpatient data from the 2006 National Survey of Ambulatory Surgery (a database of 
surgical outpatient procedures in hospital-based or freestanding clinics but not physician 
office-based procedures).(38) According to our estimates, surgical rates for SUI or POP will 
increase 42.7% by 2050. Annual procedure rates will increase from 210,700 to 310,050 for 
SUI and from 166,000 to 245,970 for POP. These data indicate surgical rates will increase 
starting from the age of 20 onward until 80 when rates will then decrease.(38) Recently, 
Kirby and colleagues examined Kaiser Permanent San Diego data and found their 
Urogynecology clinic had experienced a 116% increase in new patients annually compared 
to 2000.(39) Using past clinic data, the authors estimated the demand for care for PFDs 
would increase by 35% from 2010 to 2030.(39**) Taken together both studies indicate that a 
significant increase in both the number of women with PFDs and those seeking care for 
PFDs will occur over the next 20 to 40 years.
Recognizing this increasing burden of PFDs, research has begun to assess the capability of 
the provider workforce trained to treat these conditions. Yune and colleagues surveyed 
general gynecologists regarding comfort in managing various urogynecologic conditions and 
found that although most respondents felt comfortable managing SUI and POP, younger 
gynecologists offered less treatment options.(40) Similarly, Casiano and colleagues found 
that younger gynecologists performed mostly midurethral slings, anterior and/or posterior 
repairs and cystoscopies with few performing more complex urogynecologic procedures.
(41) Thus, the burden for providing comprehensive treatment for PFDs will increasingly fall 
on sub-specialty trained providers. In order to deliver comprehensive pelvic care, Kirby and 
colleagues estimate that 1 PFD physician specialist, 0.5 nurse practitioner, 0.5 registered 
nurse continence specialist and 0.75 pelvic floor physical therapist were needed for every 
100,000 women, with higher specialist provider demand if fewer midlevel providers are 
available.(39)
Conclusions
Pelvic floor disorders are a significant public health issue affecting the lives of millions of 
adult women. Providers should assess for PFDs regularly, especially in patients with one 
existing PFD and in older populations. Surgery can offer effective treatment for PFDs, and 
many patients with symptomatic PFDs elect to undergo surgery. As the U.S. population ages 
over the next 40 years, the burden of PFDs will become greater and the number of surgeries 
performed for PFDs per year will increase. This increased demand for PFD treatment and 
care in the future will lead to a greater need for providers properly trained in Female Pelvic 
Medicine and Reconstructive Surgery, the newest board-certified subspecialty within the 
field of Obstetrics and Gynecology.
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• PFDs are common and affect an estimated 25% of all women in the 
United States
• Approximately 20% of women will undergo surgery for stress urinary 
incontinence and pelvic organ prolapse at some point in their lives.
• Over the next 40 years as the aging population grows the number of 
women affected by PFDs will significantly increase resulting in 
increased demand for properly trained providers to give proper 
treatments and care for these burdensome disorders.
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Figure 1. Risks of SUI and POP surgery
Cumulative incidence, or lifetime risk, of surgery for stress urinary incontinence (SUI), 
pelvic organ prolapse (POP), or SUI or POP surgery from age 18 years through age 84 
years. The width of the line represents the 95% confidence interval (CI) of the cumulative 
incidence at each age. The cumulative incidence (95% CI) by age 80 years per 1,000 women 
was 200.1 (95% CI 198.7–201.5) for SUI or POP, 135.9 (95% CI 134.8–137.1) for SUI only, 
and 125.6 (95% CI 124.4–126.7) for POP only.
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